| 中文名 | 异更昔洛韦 |
|---|---|
| 英文名 | 3-[(2-Amino-6-hydroxy-9H-purin-9-yl)methoxy]-1,2-propanediol |
| 中文别名 |
更昔洛韦杂质1盐酸盐(非对映异构体混合物)
更昔诺韦相关杂质 更昔洛韦杂质E 更昔洛韦杂质E(异更昔洛韦) 2-氨基-9-(((2,3-二羟基丙氧基)甲基)-3H-嘌呤-6(9H)-酮(更昔诺韦杂质) 更昔洛韦相关物质A 标准品 盐酸缬更昔洛韦杂质10 更昔洛韦 杂质 E(更昔洛韦 相关化合物 A,异更昔洛韦) 更昔洛韦杂质 更昔洛韦杂质5(更昔洛韦杂质E) 更昔洛韦杂质05 更昔洛韦相关化合物A |
| 英文别名 |
2-amino-9-((2,3-dihydroxypropoxy)methyl)-3H-purin-6(9H)-one (Ganciclovir Impurity)
iso ganciclovir Ganciclovir Impurity E (Ganciclovir Related Compound A, Iso-Ganciclovir) 2-Amino-9-[(2,3-dihydroxypropoxy)methyl]-3,9-dihydro-6H-purin-6-one 2-amino-9-(2,3-dihydroxypropoxymethyl)-3H-purin-6-one Ganciclovir impurity E 2-amino-9-((2,3-dihydroxypropoxy)methyl)-1H-purin-6(9H)-one Ganciclovir Related Compound A (15 mg) ((RS)-2-Amino-9-(2,3-dihydroxy-propoxymethyl)-1,9-dihydro-purin-6-one) Ganciclovir Related Compound AQ: What is Ganciclovir Related Compound A Q: What is the CAS Number of Ganciclovir Related Compound A Q: What is the storage condition of Ganciclovir Related Compound A Q: What e the applications of Ganciclovir Related Compound A Ganciclovir impurities815 Ganciclovir Impurity 5(Ganciclovir Impurity E) Impurities of Valganciclovir Hydrochloride 10 UNII:NNJ00018WY 6H-Purin-6-one, 2-amino-9-[(2,3-dihydroxypropoxy)methyl]-1,9-dihydro Ganciclovir Impurity E / Ganciclovir Related Compound A Ganciclovir Impurity E (iso-Ganciclovir) Gancyclovir Impurity 9 Ganciclovir Imp. E : 2-amino-9-[[(2RS)-2,3-dihydroxypropoxy]methyl]-1,9-dihydro-6H-purin-6-one 7-acetoxy-6,8-dimethoxy-chromen-2-one Isofraxidin-acetat 2-Amino-9-[(2,3-dihydroxypropoxy)Methyl]-1,9-dihydro-6H-purin-6-one |
| 密度 | 1.8±0.1 g/cm3 |
|---|---|
| 沸点 | 689.6±65.0 °C at 760 mmHg |
| 分子式 | C9H13N5O4 |
| 分子量 | 255.231 |
| 闪点 | 370.8±34.3 °C |
| 精确质量 | 255.096756 |
| PSA | 140.27000 |
| LogP | -2.26 |
| 蒸汽压 | 0.0±2.3 mmHg at 25°C |
| 折射率 | 1.761 |
| 危险品运输编码 | NONH for all modes of transport |
|---|
|
~88%
86357-09-7 |
| 文献:Lin; Liu Tetrahedron Letters, 1984 , vol. 25, # 9 p. 905 - 906 |
|
~75%
86357-09-7 |
| 文献:Ashton; Canning; Reynolds; Tolman; Karkas; Liou; Davies; DeWitt; Perry; Field Journal of Medicinal Chemistry, 1985 , vol. 28, # 7 p. 926 - 933 |
|
~%
86357-09-7 |
| 文献:Lin; Liu Tetrahedron Letters, 1984 , vol. 25, # 9 p. 905 - 906 |
|
~%
86357-09-7 |
| 文献:Ashton; Canning; Reynolds; Tolman; Karkas; Liou; Davies; DeWitt; Perry; Field Journal of Medicinal Chemistry, 1985 , vol. 28, # 7 p. 926 - 933 |
|
~%
86357-09-7 |
| 文献:Babu, K. Srihari; Rao, M. Raghavendar; Goverdhan; Srinivas; Reddy, P. Pratap; Venkateswarlu; Anand, R. Vijaya Synthetic Communications, 2013 , vol. 43, # 13 p. 1751 - 1758 |
|
~%
86357-09-7 |
| 文献:Babu, K. Srihari; Rao, M. Raghavendar; Goverdhan; Srinivas; Reddy, P. Pratap; Venkateswarlu; Anand, R. Vijaya Synthetic Communications, 2013 , vol. 43, # 13 p. 1751 - 1758 |
|
~%
86357-09-7 |
| 文献:Babu, K. Srihari; Rao, M. Raghavendar; Goverdhan; Srinivas; Reddy, P. Pratap; Venkateswarlu; Anand, R. Vijaya Synthetic Communications, 2013 , vol. 43, # 13 p. 1751 - 1758 |
| 上游产品 3 | |
|---|---|
| 下游产品 0 | |